Cipher Pharmaceuticals Inc. Registered Shares o.N.
- BID
10.2
- ASK
10.3
- 1,186 Units1,179 Units
- 07/21, 16:31:09 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
29.94%
Market Cap
-
P/E Ratio
10.05
Dividend Yield
0.00 %
Earnings per Share
0.95 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 10.2 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:31:09 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 10.2 | 9.9 |
| PREV. DAY'S PRICE | 10.2 | (07/20) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 12 (04/15) | 6.85 (02/27) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.75 | 0.43 | 0.95 | 0.80 | 0.90 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 5.04 | 22.38 | 10.05 | 12.75 | 11.33 |
PRICE - BOOK RATIO | 1.25 | 2.49 | 2.20 | - | - |
PRICE - SALES RATIO | 4.93 | 7.90 | 5.55 | - | - |
PRICE - CASH FLOW RATIO | 6.52 | 13.49 | 9.42 | - | - |
Master Data
| WKN | A0B85L |
| ISIN | CA17253X1050 |
| SYMBOL | PHE |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | CIPHER PHARMACEUTICALS |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -1.92 % | 2.51 % | -11.30 % | 10.87 % | 29.94 % | 308.00 % | 900.00 % | 10.87 % |
| HIGH | 10.40 | 10.80 | 11.90 | 12.00 | 12.00 | 12.70 | 12.70 | 12.00 |
| LOW | 9.75 | 9.65 | 9.50 | 6.85 | 6.85 | 2.26 | 0.99 | 6.85 |
Dividende
pro Aktie
CIPHER PHARMACEUTICALS does not deliver dividend information
Company profile
Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. It offers dermatology products, hospital acute care products, out-licensed products, and specialty medicine. The company was founded on January 9, 2004 and is headquartered in Mississauga, Canada.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.